Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FGTW in pediatric congenital fibrinogen deficiency
NCT02094430Phase 3Completed
- Sponsor
- LFB Group
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of Fibrinogen human in congenital fibrinogen deficiency (CFD), sponsored by LFB Group. Started Jan 2014; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
congenital fibrinogen deficiency (CFD)
Beyond the preview
Go deeper on NCT02094430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02094430.